Introduction to a Revolutionary Cancer Approach This treatment starts with T cells from the patient. Doctors add receptors to spot…
Browsing: Clinical Trials
On September 6, 2025, at the MOASC and ANCO Immuno-Oncology Symposium, Dr. Alexis LeVee, MD, from UCLA’s Division of Hematology/Oncology,…
Genitourinary oncology is advancing fast. At the MOASC Spotlight on Oncology event on August 16, 2025, at VEA Newport Beach,…
Introduction to Datopotamab Deruxtecan EGFR-Mutated NSCLC On June 23, 2025, the FDA approved Datopotamab Deruxtecan EGFR-Mutated NSCLC treatment, known as…
Introduction to HCC Treatment Insights Hepatocellular carcinoma (HCC) presents tough treatment challenges, requiring careful patient selection for local therapies. This…
On June 11, 2025, the U.S. Food and Drug Administration (FDA) approved taletrectinib (Ibtrozi, Nuvation Bio Inc.), a new kinase…
Digestive cancers therapeutics takes center stage as these cancers—esophageal, gastric, biliary, pancreatic, hepatocellular, and colorectal—account for 33-35% of global cancer…
Tarlatamab Phase 3 Results SCLC ASCO 2025 The tarlatamab phase 3 results for SCLC, shared at ASCO 2025, showed a…
At the 2025 ASCO Annual Meeting, a phase 3 randomized trial revealed that the timing of immunotherapy in non-small cell…
Posted on May 30, 2025 by ASCO Editorial Team Artificial intelligence (AI) is reshaping the future of cancer research and…
FDA Approves Enhertu for HR-Positive, HER2-Low and HER2-Ultralow Breast Cancer: A New Milestone in Treatment Published: February 20, 2025 On…
Introduction: Recent data from the American Society of Clinical Oncology (ASCO) GI Cancers Symposium 2025, as detailed in their educational…
Date: February 8, 2025 The U.S. Food and Drug Administration (FDA) has recently granted approval for datopotamab deruxtecan (DLNK), a…
Overview of the CONFORM™ Platform The CONFORM™ platform by EDETEK offers a multifaceted approach to managing clinical data, focusing on…
Lung Cancer EGFR: What Are The Latest Advanced Treatments in 2023? Insights from Ravi Salgia MD By Ravi Salgia, MD,…